NCT00787410 An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma Status COMPLETED Phase PHASE2
NCT00748085 CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) Status TERMINATED Phase NA
NCT00715611 Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00703638 Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00685204 An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma Status UNKNOWN Phase PHASE2
NCT00668499 A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma Status WITHDRAWN Phase PHASE1/PHASE2
NCT00651456 Mesothelioma Avastin Plus Pemetrexed-cisplatin Study Status COMPLETED Phase PHASE2/PHASE3
NCT00637624 N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy Status TERMINATED Phase NA
NCT00629343 Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide Status COMPLETED Phase PHASE1
NCT00604461 Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM) Status TERMINATED Phase PHASE1/PHASE2
NCT00597116 An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma Status TERMINATED Phase PHASE2
NCT00551252 A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma Status UNKNOWN Phase PHASE2
NCT00535951 Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma Status COMPLETED Phase PHASE1
NCT00454519 Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis Status UNKNOWN Phase PHASE2
NCT00423254 Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. Status COMPLETED Phase PHASE1
NCT00407459 Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma Status COMPLETED Phase PHASE2
NCT00402766 Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma Status COMPLETED Phase PHASE1
NCT00325494 A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer Status COMPLETED Phase PHASE1